Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by β-adrenergic signaling

British Journal of Pharmacology

Volumn 140, Issue 6, 2003, Pages 1019-1026

  Lutz, Susanne ^a   Mura, Roman A ^a   Hippe, Hans Joerg ^a   Tiefenbacher, Christiane ^a   Niroomand, Feraydoon ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

adrenergic receptor; Adenylyl cyclase; G protein; Heart failure

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (2 THIODIPHOSPHATE); GUANOSINE DIPHOSPHATE; HEART ENZYME; ISOPRENALINE; LIOTHYRONINE; METOPROLOL; NUCLEOSIDE DIPHOSPHATE KINASE A; PROPRANOLOL; THYROID HORMONE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HEART MUSCLE FIBER MEMBRANE; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOLEMMA; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANIMALS; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; HEART DEFECTS, CONGENITAL; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MYOCARDIUM; NUCLEOSIDE-DIPHOSPHATE KINASE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; SARCOLEMMA; THYROID HORMONES; TIME FACTORS;

EID: 0344394437     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705527     Document Type: Article

References (45)

1. ANONYMOUS (1999a). Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet, 353, 2001-2007.
2. ANONYMOUS (1999b). The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet, 353, 1-13.
3. BOND, R.A., LEFF, P., JOHNSON, T.D., MILANO, C.A., ROCKMAN, H.A., MCMINN, T.R., APPARSUNDARAM, S., HYEK, M.F., KENAKIN, T.P. & ALLEN, L.F. (1995). Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature, 374, 272-276.
4. BRISTOW, M.R., GINSBURG, R., MINOBE, W., CUBICCIOTTI, R.S., SAGEMAN, W.S., LURIE, K., BILLINGHAM, M.E., HARRISON, D.C. & STINSON, E.B. (1982). Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N. Engl. J. Med., 307, 205-211.
5. BROWN, L.A. & HARDING, S.E. (1992). The effect of pertussis toxin on beta-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure. Br. J. Pharmacol., 106, 115-122.
6. CUELLO, F., SCHULZE, R.A., HEEMEYER, F., MEYER, H.E., LUTZ, S., JAKOBS, K.H., NIROOMAND, F. & WIELAND, T. (2003). Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits. Complex formation of NDPK B with Gbeta gamma dimers and phosphorylation of His-266 IN Gbeta. J. Biol. Chem., 278, 7220-7226.
7. EMMELOT, P., BOS, C.J., BENEDETTI, E.L. & RÜMKE, P. (1964). Studies on plasma membranes. I. Chemical composition and enzyme content of plasma membranes from rat liver. Biochim. Biophys. Acta, 90, 126-145.
8. FELDMAN, A.M., CATES, A.E., VEAZEY, W.B., HERSHBERGER, R.E., BRISTOW, M.R., BAUGHMAN, K.L., BAUMGARTNER, W.A. & VAN DOP, C. (1988). Increase of the 40 000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J. Clin. Invest., 82, 189-197.
9. FISKE, C.H. & SUBBAROW, Y. (1925). The colorimetric determination of phosphorus. J. Biol. Chem., 66, 375-400.
10. FOURNIER, H.N., DUPET-MANET, S., BOUVARD, D., LACOMBE, M.L., MARIE, C., BLOCK, M.R. & ALBIGES-RIZO, C. (2002). Integrin cytoplasmic domain-associated protein 1α (ICAP-1α) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J. Biol. Chem., 277, 20895-20902.
11. GILBERT, E.M., ABRAHAM, W.T., OLSEN, S., HATTLER, B., WHITE, M., MEALY, P., LARRABEE, P. & BRISTOW, M.R. (1996). Comparative hemodynamic, left ventricular functional, and anti-adrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation, 94, 2817-2825.
12. HALL, J.A., KAUMANN, A.J. & BROWN, M.J. (1990). Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium. Circ. Res., 66, 1610-1623.
13. HARTSOUGH, M.T., MORRISON, D.K., SALERNO, M., PALMIERI, D., OUATAS, T., MAIR, M., PATRICK, J. & STEEG, P.S. (2002). Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J. Biol. Chem., 277, 32389-32399.
14. HEILBRUNN, S.M., SHAH, P., BRISTOW, M.R., VALANTINE, H.A., GINSBURG, R. & FOWLER, M.B. (1989). Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation, 79, 483-490.
15. HERMAN, R.B., JESUDASON, P.J., MUSTAFA, A.M., HUSAIN, R., CHOY, A.M. & LANG, C.C. (2003). Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans. Br. J. Clin. Pharmacol., 55, 134-138.
16. HIPPE, H.J., LUTZ, S., CUELLO, F., KNORR, K., VOGT, A., JAKOBS, K.H., WIELAND, T. & NIROOMAND, F. (2003). Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits. Specific activation of Gsalpha by an NDPK B.Gbetagamma complex in H10 cells. J. Biol. Chem., 278, 7227-7233.
17. JAKOBS, K.H., SAUR, W. & SCHULTZ, G. (1976). Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J. Cyclic Nucleotide Res., 2, 381-392.
18. JONES, L.R. (1988). Rapid preparation of canine cardiac sarcolemmal vesicles by sucrose flotation. Methods Enzymol., 157, 1983-1989.
19. + )-ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles. J. Biol. Chem., 255, 9971-9980.
20. KIMURA, N. (1993). Role of nucleoside diphosphate kinase in G-protein action. In: Handbook of Experimental Pharmacology. eds. Dickey, B.F. & Birnbaumer, L., pp. 485-498. Berlin: Springer-Verlag.
21. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 221, 680-685.
22. LUTZ, S., MURA, R., BALTUS, D., MOVSESIAN, M.A., KÜBLER, W. & NIROOMAND, F. (2001). Increased activity of membrane-associated nucleoside diphosphate kinase and inhibition of cAMP synthesis in failing human myocardium. Cardiovasc. Res., 49, 48-55.
23. MARKS, A.R., PRIORI, S., MEMMI, M., KONTULA, K. & LAITINEN, P.J. (2002). Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J. Cell. Physiol., 190, 1-6.
24. MARX, S.O., REIKEN, S., HISAMATSU, Y., JAYARAMAN, T., BURKHOFF, D., ROSEMBLIT, N. & MARKS, A.R. (2000). PKA phosphorylation dissociates FKBP12. 6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell, 101, 365-376.
25. METRA, M., GIUBBINI, R., NODARI, S., SOLDI, E., MODENA, M.G. & DEI, C.L. (2000). Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation, 102, 546-551.
26. MINAMISAWA, S., HOSHIJIMA, M., CHU, G., WARD, C.A., FRANK, K., GU, Y., MARTONE, M.E., WANG, Y., ROSS, J., KRANIAS, E.G., GILES, W.R. & CHIEN, K.R. (1999). Chronic phospholambansarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell, 99, 313-322.
27. MOON, H., LEE, B., CHOI, G., SHIN, D., PRASAD, D.T., LEE, O., KWAK, S.S., KIM, D.H., NAM, J., BAHK, J., HONG, J.C., LEE, S.Y., CHO, M.J., LIM, C.O. & YUN, D.J. (2003). NDP kinase 2 interacts with two oxidative stress-activated MAPKs to regulate cellular redox state and enhances multiple stress tolerance in transgenic plants. Proc. Natl. Acad. Sci. U.S.A., 100, 358-363.
28. NEUMANN, J., SCHMITZ, W., SCHOLZ, H., VON MEYERINCK, L., DURING, V. & KALMAR, P. (1988). Increase in myocardial Gi-proteins in heart failure. Lancet, 2, 936-937.
29. NIROOMAND, F., PIACENTINI, L., JAKOBS, K.H., MURA, R., RAUCH, B. & KÜBLER, W. (1997). Receptor-independent activation of cardiac sarcolemmal adenylyl cyclase by GDP and membrane-associated nucleoside diphosphate kinase. A new cardiotonic mechanism? J. Mol. Cell. Cardiol., 29, 1479-1486.
30. OSTMAN-SMITH, I. (1995). Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat. Br. J. Pharmacol., 116, 2703-2709.
31. OTERO, A.D. (1990). Transphosphorylation and G protein activation. Biochem. Pharmacol., 39, 1399-1404.
32. OTERO, A.S. (2000). NM23/nucleoside diphosphate kinase and signal transduction. J. Bioenerg. Biomembr., 32, 269-275.
33. OTSUKI, Y., TANAKA, M., YOSHII, S., KAWAZOE, N., NAKAYA, K. & SUGIMURA, H. (2001). Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiaml. Proc. Natl. Acad. Sci. U.S.A., 98, 4385-4390.
34. PIACENTINI, L. & NIROOMAND, F. (1996). Phosphotransfer reactions as a means of G protein activation. Mol. Cell. Biochem., 157, 59-63.
35. SANDERS, L., LYNHAM, J.A., BOND, B., DEL MONTE, F., HARDING, S.E. & KAUMANN, A.J. (1995). Sensitization of human atrial 5-HT4 receptors by chronic beta-blocker treatment. Circulation, 92, 2526-2539.
36. SANDERS, L., LYNHAM, J.A. & KAUMANN, A.J. (1996). Chronic beta 1-adrenoceptor blockade sensitises the H1 and H2 receptor systems in human atrium: role of cyclic nucleotides. Naunyn Schmiedebergs Arch. Pharmacol., 353, 661-670.
37. SIGMUND, M., JAKOB, H., BECKER, H., HANRATH, P., SCHUMACHER, C., ESCHENHAGEN, T., SCHMITZ, W., SCHOLZ, H. & STEINFATH, M. (1996). Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure. Eur. J. Clin. Pharmacol., 51, 127-132.
38. SQUIRE, I.B. & BARNETT, D.B. (2000). The rational use of beta-adrenoceptor blockers in the treatment of heart failure. The changing face of an old therapy. Br. J. Clin. Pharmacol., 49, 1-9.
39. UNGERER, M., BÖHM, M., ELCE, J.S., ERDMANN, E. & LOHSE, M.J. (1993). Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation, 87, 454-463.
40. WIELAND, T., NURNBERG, B., ULIBARRI, I., KALDENBERG STASCH, S., SCHULTZ, G. & JAKOBS, K.H. (1993). Guanine nucleotide-specific phosphate transfer by guanine nucleotide-binding regulatory protein beta-subunits. Characterization of the phosphorylated amino acid. J. Biol. Chem., 268, 18111-18118.
41. WIELAND, T., RONZANI, M. & JAKOBS, K.H. (1992). Stimulation and inhibition of human platelet adenylylcyclase by thiophosphorylated transducin beta gamma-subunits. J. Biol. Chem., 267, 20791-20797.
42. WITTE, K., SCHNECKO, A., HAUTH, D., WIRZIUS, S. & LEMMER, B. (1998). Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters. Br. J. Pharmacol., 125, 1033-1041.
43. 2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure. Cardiovasc. Res., 44, 146-155.
44. YOSHIKAWA, T., PORT, J.D., ASANO, K., CHIDIAK, P., BOUVIER, M., DUTCHER, D., RODEN, R.L., MINOBE, W., TREMMEL, K.D. & BRISTOW, M.R. (1996). Cardiac adrenergic receptor effects of carvedilol. Eur. Heart J., 17 (Suppl. B), 8-16.
45. ZHU, J., TSENG, Y.H., KANTOR, J.D., RHODES, C.J., ZETTER, B.R., MOYERS, J.S. & KAHN, C.R. (1999). Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. Proc. Natl. Acad. Sci. U.S.A., 96, 14911-14918.